[B-cell lymphoma and low aggressiveness: from the historical paradigm of a clinico-biological entity to the challenge of an effective therapeutic strategy].
Sánchez Fayos
J
J
Servicio de Hematología y Hemoterapia, Fundación Jiménez Díaz, Universidad Autónoma, Madrid.
Nevado
I
I
Richart
A
A
Chica
E
E
Loscertales
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D049673:History, 20th Century; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000145:classification / Q000266:history / Q000473:pathology / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000145:classification / Q000266:history / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D011867:Radioisotope Teletherapy; D012074:Remission Induction
D007155:Immunologic Factors